Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
2 min synopsisUK scopeSources checked 27 Aug 2026Clinical review pending
!
Escalate
Do not attribute collapse to postural hypotension when there is exertional syncope, chest pain, new breathlessness, sustained palpitations, focal neurology, major bleeding, persistent hypotension or serious injury. These features need urgent assessment for cardiac, neurological, haemorrhagic or septic causes.
Synopsis
Confirm a reproducible orthostatic BP fall, identify reversible causes and use staged non-drug and drug treatment without provoking supine hypertension.
In a person with postural dizziness or falls, measure BP lying or seated and again after standing for at least 1 minute.
A fall of at least 20 mmHg systolic or 10 mmHg diastolic supports postural hypotension; symptoms can still be important when the threshold is not captured once.
Record heart-rate response and symptoms with the BP: a blunted pulse rise suggests autonomic failure, whereas marked tachycardia suggests volume loss or another orthostatic syndrome.
Key red flags
Alternative dangerous cause
Exertional or supine syncope, chest pain, abrupt dyspnoea, persistent palpitations, melaena/haematemesis, focal neurology, sepsis features or family history of sudden death.
Investigation priorities
01
Lying-to-standing BP and pulseFirst step
Demonstrate the haemodynamic change and relate it to symptoms.
Management branches
confirmSymptoms on standing
Dizziness, presyncope, syncope or unexplained falls related to posture.
First: assess ABCs, injury, bleeding, infection, neurological deficit and cardiac red flags; use the urgent pathway if present.
Next: record lying or seated BP/pulse and repeat after standing for at least 1 minute, documenting symptoms and considering a 3-minute reading.
Key medicines
Midodrine2.5 mg orally three times daily initially during waking hours; increase at weekly intervals according to response up to 10 mg three times daily. Take the final dose at least 4 hours before bedtime.
Fludrocortisone (off-label)100 micrograms orally once daily is the adult regimen used in the placebo-controlled evidence summarised by NICE; any titration should be specialist-directed.
National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.